论文信息 - A New Trade Framework for Global Healthcare R&D

A New Trade Framework for Global Healthcare R&D

Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives

Tim Hubbard | James Love | J. Love | T. Hubbard

[1] Brian D. Wright. The Economics of Invention Incentives: Patents, Prizes, and Research Contracts , 1983 .

[2] M. Kremer. Patent Buy-Outs: A Mechanism for Encouraging Innovation , 1997 .

[3] C. Correa. Integrating public health concerns into patent legislation in developing countries , 2000 .

[4] D. Wirth,et al. Drugs for neglected diseases: a failure of the market and a public health failure? , 2001, Tropical medicine & international health : TM & IH.

[5] Gene patents and the public good , 2003, Nature.

[6] D. Butler. Drive for patent-free innovation gathers pace , 2003, Nature.

[7] Tropical diseases: Raiding the medicine cabinet , 2003, Nature.

[8] J. Love,et al. Medicines without barriers , 2003 .

[9] J. Aronson. Dying for Drugs , 2003, BMJ : British Medical Journal.

[10] M. Eisen,et al. Why PLoS Became a Publisher , 2003, PLoS biology.

[11] Andrés Guadamuz González,et al. Information Feudalism: Who owns the Knowledge Economy? , 2004, Int. J. Law Inf. Technol..